Fluvastatin
Indications: - Mixed hyperlipidaemia - Coronary atherosclerosis Source: EML workbook import

Browse procurement-ready healthcare products from trusted vendors across the Afya Chain marketplace.
Indications: - Mixed hyperlipidaemia - Coronary atherosclerosis Source: EML workbook import
Indications: - Mixed hyperlipidaemia - Coronary atherosclerosis Source: EML workbook import
Indications: - Mixed hyperlipidaemia - Coronary atherosclerosis Source: EML workbook import
Formulations: - Oral > Solid: 5 mg; 10 mg; 20 mg; 40 mg - Oral > Solid: 20 mg Indications: - Mixed hyperlipidaemia - Coronary atherosclerosis - Polycystic ovary syndrome Source: EML workbook import
Formulations: - Parenteral > Locoregional injections > Spinal anaesthesia: 0.5% in 4 mL ampoule (hydrochloride) + 8% glucose solution Parenteral > General injections > unspecified: 0.25% (hydrochloride); 0.5% (hydrochloride) Indications: - Local anaesthetics Source: EML workbook import
Formulations: - Parenteral > Locoregional injections > Spinal anaesthesia: 30 mg per mL in 1 mL ampoule (ephedrine hydrochloride) Indications: - Cardiac complications of anaesthesia during labour or delivery Source: EML workbook import
Formulations: - Parenteral > Locoregional injections > Other: 1% (lidocaine hydrochloride OR lidocaine sulfate) + 1:200 000 epinephrine; 2% (lidocaine hydrochloride OR lidocaine sulfate) + 1:200 000 epinephrine Local > Dental > Cartridge: 2% (lidocaine hydrochloride) + 1:80 000 epinephrine Indications: - Local anaesthetics Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 0.5 mg per mL in alcohol Indications: - Other specified congenital anomaly of great arteries including arterial duct Source: EML workbook import
Formulations: - Respiratory > Suspension: 25 mg per mL for intratracheal instillation Indications: - Respiratory distress syndrome of newborn Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 20 mg per mL (equivalent to 10 mg caffeine base per mL) Oral > Liquid: 20 mg per mL (equivalent to 10 mg caffeine base per mL) Indications: - Apnoea of newborn Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 1 mg per mL Indications: - Other specified congenital anomaly of great arteries including arterial duct Source: EML workbook import
Formulations: - Oral > Liquid: 100 mg per 5 mL; 200 mg per 5 mL Oral > Solid > tablet: 200 mg; 400 mg - Oral > Liquid: 200 mg per 5 mL; 100 mg per 5 mL Oral > Solid > tablet: 200 mg; 400 mg; 600 mg Indications: - Migraine - Pain Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.